KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash from Operations (2016 - 2025)

Opko Health (OPK) has disclosed Cash from Operations for 16 consecutive years, with 25921000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 41.63% year-over-year to 25921000.0, compared with a TTM value of 178542000.0 through Dec 2025, up 2.7%, and an annual FY2025 reading of 178542000.0, up 2.7% over the prior year.
  • Cash from Operations was 25921000.0 for Q4 2025 at Opko Health, up from 34647000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 33395000.0 in Q3 2021 and bottomed at 83420000.0 in Q2 2025.
  • Average Cash from Operations over 5 years is 22354000.0, with a median of 26178000.0 recorded in 2024.
  • The sharpest move saw Cash from Operations skyrocketed 202.71% in 2023, then tumbled 7142.47% in 2024.
  • Year by year, Cash from Operations stood at 5643000.0 in 2021, then tumbled by 460.34% to 31620000.0 in 2022, then dropped by 21.11% to 38294000.0 in 2023, then dropped by 15.97% to 44409000.0 in 2024, then surged by 41.63% to 25921000.0 in 2025.
  • Business Quant data shows Cash from Operations for OPK at 25921000.0 in Q4 2025, 34647000.0 in Q3 2025, and 83420000.0 in Q2 2025.